Cambridge tutor scheme sees grades rise for Stem students
More than 700 sixth form students have increased their grades and secured places at top universities after taking part in a free weekly tutoring programme.The Universities and Colleges Admissions Service (Ucas) said pupils who took part in Cambridge University's STEM SMART scheme performed better than their peers.The university said the project aimed to mitigate educational disruption caused by the pandemic and bridge attainment gaps in maths and science A-level subjects.Lisa Jardine-Wright, University of Cambridge physics lecturer, said the scheme had the capacity to support every science, technology, engineering and mathematics (Stem) sixth former in state schools for free.
The University of Cambridge said the scheme was launched in response to challenges faced by state schools teaching physical sciences, in particular physics. It said in England there was an estimated national shortage of at least 3,500 physics teachers.Jasmine Covell, 18, who is now a first year natural sciences undergraduate at King's College, Cambridge, said Oxbridge had not been on the radar where she lived as most people applied to local universities to save on accommodation costs.She studied A-level biology, chemistry and maths at a college near Middlesbrough and was in Year 9 when the first lockdown took place."It definitely helped with catching up on work we'd missed during Covid," she said after completing the Cambridge scheme. "We got behind on some of the content, particularly the more advanced stuff, so it was great to get the extra learning through STEM SMART."Ucas analysis of the scheme compared the first two cohorts (1,120 pupils) with 9,000 pupils from similar backgrounds. It said those who received the tuition were more aspirational and sixth formers from more disadvantaged backgrounds saw the biggest average grade boost. Samuel Iranloye, 19, joined the first cohort while studying A-level maths, further maths, physics and chemistry in south-east London. Now a second-year engineering undergraduate at Churchill College, Cambridge, he said his experiences visiting the university during the scheme influenced his choice."The extra tuition also helped consolidate the learning in school. It also helped me when it came to preparing for my university admission tests," he said.
The scheme aimed to address an attainment gap that already existed in the UK, which was then exacerbated by the pandemic, said Ms Jardine-Wright, a co-director of the programme.She said: "This is about levelling the playing field and enabling students from educationally disadvantaged and underrepresented backgrounds to access Cambridge and other competitive universities."Ucas found students who engaged the most in the scheme saw their results rise by a grade, were up to four times as successful in achieving A*s as their peers, and were almost twice as successful in securing a place at Oxbridge.
Follow Cambridgeshire news on BBC Sounds, Facebook, Instagram and X.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
19 hours ago
- The Independent
Covid surge in Asia sparks concern about emergence of more infectious variants
India, Thailand, Indonesia, and several other countries in Asia have seen a surge in Covid cases since mid-May, sparking concerns about the emergence of more infectious variants of the novel coronavirus. India, which currently has more than 5,700 active Covid cases, reported four deaths from the infection over the last 24 hours. Although hospitalisations due to Covid remain low, India's health ministry is urging the public to remain careful, get tested quickly when symptoms appear, and continue to use masks in crowded spaces. In Thailand, hundreds of Covid patients have required hospitalisation since the beginning of June, while at least one has succumbed to the virus. The country reported 28,300 cases over just the first two days of this month, with the Bangkok metropolitan area accounting for the bulk of them. According to the Department of Disease Control, at least 70 people have died from Covid in the Southeast Asian country so far in 2025, mostly in large cities. The death rate has hovered around 0.106 per 100,000 people, suggesting the virus has not become deadlier. Indonesia has advised its healthcare institutions to remain vigilant and boost Covid surveillance amid a surge in infections attributed to new highly transmissible but less deadly variants of the coronavirus. "Cases are indeed increasing, but the rise is caused by variants that are relatively less deadly,' health minister Budi Gunadi Sadikin told reporters earlier this week. Health authorities are monitoring Omicron subvariants LF.7 and NB.1.8.1 for driving the ongoing surge in infections in Asia. These strains are not yet labelled as variants of concern but are only suspected to be causing an increase in Covid cases. The NB.1.8.1 subvariant has previously been reported in Thailand, Australia, China, Britain and the US. It's already known to be a recombinant virus formed from the merging of two coronavirus variants. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spread more easily than other variants. Studies of the variant on cultured laboratory tissues reveal that the new strain has the strongest ability to bind to human cell receptors, facilitating its entry into cells. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Fatigue, sore throat, nasal congestion, and gut discomfort are widely reported to be the main symptoms of infection by the new strains. According to the World Health Organisation, current Covid vaccines should protect against severe symptoms caused by the newly reported variants. In India, though, nearly 50 per cent of the new infections are still caused by the older JN.1 strain, according to data from the country's SARS-CoV-2 Genomics Consortium. Most people who get infected experience only mild symptoms that disappear on their own or with over-the-counter drugs such as cough medicines, analgesics and decongestants. However, vulnerable groups such as the elderly or those with comorbid conditions are being urged to seek hospital care if symptoms appear. Healthcare experts urge infected individuals experiencing shortness of breath, extreme fatigue or blood oxygen levels below 95 per cent to immediately seek medical attention.
Daily Mail
2 days ago
- Daily Mail
Shock Covid warning: Ultra-catchy 'Nimbus' variant could trigger summer wave amid 97 per cent infection surge
A new highly contagious Covid variant could spark a wave of infections this summer, scientists have warned. Dubbed 'Nimbus', the strain is descended from the already super virulent Omicron and has already triggered a surge in cases in China, Singapore and Hong Kong. Data from the UK Health Security Agency (UKHSA) also shows 13 cases of Nimbus, known scientifically as N.B.1.8.1, have already been detected in England. And 25 British samples of the strain have been submitted to an international Covid database since the end of March. However, both figures are likely an underestimation of how far the variant has spread given how testing has been massively reduced from the height of the pandemic. Other UKHSA data show the percentage of people testing positive for Covid has risen to its highest point this year, and is already 97 per cent higher than the level recorded in March. Now, British scientists have warned Nimbus could lead to a surge in Covid cases in a matter of weeks, and have urged the vulnerable to get vaccinated. They warn that many people's immunity to the virus, built up from previous infections and older jabs, has likely faded meaning they could be at higher risk of falling ill. Professor Lawrence Young, a virologist at Warwick University, said Nimbus had the potential to drive a surge in cases as the weather warms up and people become more sociable. 'We are very likely to see a spike of infections over the next couple of months, possibly by later this month or in July. But it's difficult to predict the level of this infection wave,' he told The i Paper. 'Population immunity, either from vaccination or previous infection, is waning and, unlike other respiratory viruses such as flu, the Covid virus continues to spread in hot and humid weather,' he said. He added lab studies suggest Nimbus can infect human cells more efficiently than previous strains, and that it may have increased ability to dodge the immune system, making it more likely to infect people. There is currently no evidence that the strain is more likely to cause severe illness or death in those it infects, compared to previous strains. However, infection with the virus can still be deadly for more vulnerable groups. Covid was a factor in the deaths of just over 300 people in England in May, according to the latest official figures. Nimbus now accounts for 10.7 per cent of Covid infections worldwide, according to the World Health Organisation (WHO), compared to just 2.5 per cent a month prior. Last month the UN-body declared the strain a 'variant under monitoring'. This means that the WHO is tracking the virus, watching for signs it could pose a significant threat to the public which would promote it to a 'variant of concern'. Experts have also said that current Covid vaccines, which have been reformulated to combat Omicron descendants, are expected to remain effective against Nimbus. Symptoms of Nimbus do not appear to differ from other Covid variants and include fatigue, fever, muscle ache and a sore throat. UKHSA data on Covid tests, which goes up to June 1, show 6.1 per cent of the people who were tested that week were positive for the virus, the highest figure for 2025 so far. This is a seven per cent rise from last week's figure and a 97 per cent increase from that recorded at the beginning of March. Dr Gayatri Amirthalingam, UKHSA's deputy director, said the organisation was keeping a close eye on Nimbus. 'UKHSA is monitoring all available data relating to SARS-CoV-2 variants in the UK and abroad, and we continue to publish our findings in our regular Flu and Covid-19 surveillance reports,' she said. 'NB.1.8.1 has been detected in small numbers in the UK to date, but international data suggests that it is growing as a proportion of all Covid-19 cases.' Currently adults over the age of 75, care home residents staff as well as people with a weakened immune system are eligible for a free Covid vaccine in Britain. UKHSA data suggests people who had a Covid jab as part of last spring's booster campaign were 45 per cent less likely to need hospital care for the virus in the weeks that followed compared to the unvaccinated. The agency has urged all people eligible for a vaccine to get jabbed to protect themselves from both NB.1.8.1 and Covid in general.
Daily Mirror
2 days ago
- Daily Mirror
Symptoms of 'different' Nimbus virus as UKHSA confirms it has reached UK
Doctors say the virus appears to be able to spread easily and has already been detected in 22 countries For many of us, Covid-19 feels like a chapter we've closed – along with the days of PCR tests, mask mandates and daily case updates. But while life may feel back to normal, the virus hasn't completely vanished. In fact, new variants continue to quietly circulate. One of the latest to appear on the radar is NB.1.8.1 – a name that you may have seen pop up in headlines and on social media feeds this week. This newly emerging sub-variant hasn't triggered widespread concern, but it has caught the attention of scientists and health officials. The UK Health Security Agency (UKHSA) announced this week that NB.1.8.1 has so far only been detected in small numbers within the UK, but added that international data indicates that the sub-variant is steadily accounting for a growing share of global Covid-19 cases. We consulted some GPs to find out exactly what sets the NB.1.8.1 Covid variant apart from the rest. Is it more contagious, more immune-evasive, or simply another step in Covid's slow evolution? Here's what they know so far… What is the new NB.1.8.1 Covid variant and where has it come from? 'The NB.1.8.1 variant, also referred to as Nimbus, is a new strain of the Covid-19 virus that has emerged due to mutations in its genetic material,' says Dr Naveed Asif, GP at The London General Practice. It's a sub-variant of Omicron, says Dr Chun Tang, GP at Pall Mall Medical. 'Variants like this pop up when the virus mutates, which is normal for viruses, especially ones that spread widely,' explains Tang. 'NB.1.8.1 was first picked up in early 2025 and has since been detected in several countries, including the UK, China and US. It's got some new mutations that scientists are keeping a close eye on.' How is Nimbus different from previous variants? 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity,' says Tang. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' However, Nimbus does appear to be more transmissible than previous variants, with notable increases reported in India, Hong Kong, Singapore, and Thailand, notes Asif. 'Its spread has been identified in around 22 countries,' says Asif. 'The World Health Organization (WHO) assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' How is Nimbus spreading? 'It's spreading in the usual way, person to person, mainly through respiratory droplets when people cough, sneeze or even just talk closely,' says Tang. 'Like other variants, it can hang around in the air in poorly ventilated spaces.' What Nimbus Covid symptoms should people look out for? 'Common symptoms of the NB.1.8.1 variant include severe sore throat (described as a 'razor blade sensation'), fatigue, mild cough, fever, muscle aches and congestion,' says Asif. 'However, symptoms can vary widely so vigilance is key.' What are the Nimbus treatment options? 'Treatment for Nimbus generally aligns with that for other Covid-19 variants,' says Asif. 'Most individuals will recover at home with rest, hydration, and over-the-counter medications for symptom management. 'For those with severe symptoms or high-risk complications, antiviral medications or monoclonal antibody treatments may be recommended. Always consult your GP for personalised advice.' How can you avoid getting the Nimbus variant? 'Make sure everyone's up to date with their Covid-19 jabs, especially boosters,' recommends Tang. 'Wash your hands regularly, keep rooms well ventilated, and consider popping a mask on in busy places or if you're around people who are more vulnerable. 'If someone in the house is feeling poorly, try to keep some distance and clean shared surfaces regularly.' When should you see a GP about Covid? 'Seek medical advice if you experience Covid-19 symptoms, especially if they worsen or if you have underlying health conditions that increase your risk,' advises Asif. 'Additionally, consult your GP if you've been in close contact with someone who has tested positive for the NB.1.8.1 variant or if you have health concerns.'
